Profile data is unavailable for this security.
About the company
Orchestra BioMed Holdings, Inc. is a biomedical innovation company. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The Company develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.
- Revenue in USD (TTM)2.82m
- Net income in USD-75.10m
- Incorporated2023
- Employees70.00
- LocationOrchestra Biomed Holdings Inc150 Union Square DriveNEW HOPE 18938United StatesUSA
- Phone+1 (646) 343-9298
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OraSure Technologies Inc | 125.70m | -60.24m | 215.92m | 501.00 | -- | 0.6009 | -- | 1.72 | -0.8107 | -0.8107 | 1.69 | 5.01 | 0.2834 | 2.07 | 4.91 | 250,904.20 | -13.08 | -0.8506 | -14.16 | -0.9596 | 40.41 | 44.80 | -46.15 | -1.39 | 6.20 | -- | 0.0005 | -- | -54.17 | 3.75 | -136.34 | -- | -16.43 | -- |
| CVRx Inc | 56.65m | -53.31m | 223.39m | 223.00 | -- | 5.68 | -- | 3.94 | -2.04 | -2.04 | 2.17 | 1.49 | 0.4756 | 0.6837 | 5.68 | 254,040.40 | -44.76 | -39.12 | -49.79 | -42.10 | 85.33 | 82.74 | -94.10 | -130.77 | 6.72 | -8.80 | 0.5574 | -- | 10.45 | 56.40 | 11.10 | -- | 13.27 | -- |
| KORU Medical Systems Inc | 39.07m | -3.71m | 224.66m | 80.00 | -- | 13.64 | -- | 5.75 | -0.0807 | -0.0807 | 0.8482 | 0.3557 | 1.43 | 3.53 | 7.39 | 488,383.00 | -13.62 | -19.85 | -18.41 | -23.16 | 62.32 | 59.62 | -9.50 | -24.86 | 1.92 | -- | 0.0335 | -- | 17.98 | 7.75 | 55.85 | -- | 25.82 | -- |
| Cibus Inc | 3.79m | -118.90m | 226.11m | 157.00 | -- | 3.47 | -- | 59.60 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| CapsoVision Inc | 13.09m | -22.56m | 243.12m | -- | -- | 11.88 | -- | 18.58 | -0.4873 | -0.4873 | 0.2826 | 0.4368 | -- | -- | -- | -- | -- | -- | -- | -- | 53.13 | -- | -172.37 | -- | 4.50 | -- | 0.00 | -- | 20.54 | -- | -76.01 | -- | -- | -- |
| 908 Devices Inc | 56.20m | -33.27m | 243.94m | 246.00 | -- | 1.70 | -- | 4.34 | -0.9382 | 0.5537 | 1.54 | 3.97 | 0.3215 | 1.90 | 4.69 | -- | -19.04 | -17.00 | -22.92 | -18.87 | 50.58 | 52.42 | -59.21 | -73.41 | 3.86 | -- | -- | -- | 17.70 | 15.88 | 37.38 | -- | -- | -- |
| Simulations Plus Inc | 78.68m | -64.25m | 248.81m | 212.00 | -- | 1.96 | -- | 3.16 | -3.20 | -3.20 | 3.90 | 6.31 | 0.4701 | -- | 4.28 | 371,113.20 | -38.39 | -2.50 | -40.84 | -2.65 | 59.60 | 69.96 | -81.66 | -7.29 | -- | -- | 0.00 | -- | 13.09 | 13.74 | -750.17 | -- | 7.57 | -24.21 |
| Applied Energetics Inc | 1.15m | -13.02m | 256.97m | 21.00 | -- | -- | -- | 222.85 | -0.0599 | -0.0599 | 0.0053 | -0.0033 | 0.3065 | -- | 7.70 | 54,908.57 | -345.27 | -139.08 | -454.84 | -208.36 | 58.58 | 60.61 | -1,126.59 | -473.16 | -- | -- | -- | -- | -7.78 | -- | -24.71 | -- | 51.42 | -- |
| Orchestra Biomed Holdings Inc | 2.82m | -75.10m | 257.48m | 70.00 | -- | 5.89 | -- | 91.37 | -1.82 | -1.82 | 0.0676 | 0.7746 | 0.0313 | 0.6578 | 33.75 | 40,257.14 | -83.39 | -- | -104.85 | -- | 93.01 | -- | -2,665.05 | -- | 4.72 | -- | 0.2451 | -- | -4.42 | -- | -24.23 | -- | -- | -- |
| Clearpoint Neuro Inc | 34.33m | -23.14m | 265.95m | 115.00 | -- | 16.01 | -- | 7.75 | -0.8264 | -0.8264 | 1.23 | 0.5584 | 0.6829 | 1.95 | 7.52 | 298,539.10 | -46.03 | -35.94 | -54.48 | -41.48 | 61.31 | 63.49 | -67.40 | -74.87 | 5.56 | -92.37 | 0.6479 | -- | 31.04 | 22.85 | 14.37 | -- | 11.41 | -- |
| Shoulder Innovations Inc | 41.63m | -34.45m | 270.09m | 61.00 | -- | 1.83 | -- | 6.49 | -1.91 | -1.91 | 2.24 | 7.18 | -- | -- | -- | -- | -- | -- | -- | -- | 76.67 | -- | -82.75 | -- | 9.80 | -- | 0.0913 | -- | 64.07 | -- | -50.85 | -- | -- | -- |
| Quanterix Corp | 138.90m | -107.15m | 275.07m | 450.00 | -- | 0.9263 | -- | 1.98 | -2.52 | -2.52 | 3.26 | 6.33 | 0.3366 | 1.69 | 4.47 | 308,660.00 | -25.97 | -15.56 | -30.25 | -17.25 | 46.77 | 54.07 | -77.14 | -53.54 | 2.11 | -- | 0.00 | -- | 1.07 | 9.97 | -178.09 | -- | -7.85 | -- |
| Sight Sciences Inc | 76.05m | -46.11m | 286.04m | 216.00 | -- | 4.42 | -- | 3.76 | -0.8955 | -0.8955 | 1.47 | 1.23 | 0.5854 | 1.42 | 6.71 | 352,092.60 | -35.49 | -35.50 | -39.37 | -38.53 | 86.83 | 82.63 | -60.63 | -94.20 | 8.93 | -76.38 | 0.384 | -- | -1.47 | 27.89 | 7.27 | -- | -10.54 | -- |
| Senseonics Holdings Inc | 35.26m | -69.11m | 286.96m | 130.00 | -- | 4.64 | -- | 8.14 | -1.65 | -1.65 | 0.8454 | 1.48 | 0.311 | 3.50 | 3.83 | 271,207.70 | -60.97 | -52.92 | -84.54 | -64.66 | 44.71 | 19.33 | -196.03 | -334.42 | 4.55 | -90.75 | 0.3683 | -- | 56.89 | 48.10 | 12.09 | -- | 43.88 | -- |
| Trubridge Inc | 349.88m | 5.42m | 288.47m | 3.20k | 51.82 | 1.60 | 9.00 | 0.8245 | 0.3709 | 0.3709 | 24.23 | 12.02 | 0.8737 | 257.08 | 6.17 | 109,338.40 | 1.39 | -0.9107 | 1.60 | -1.03 | 53.16 | 50.13 | 1.59 | -1.14 | 1.90 | 2.40 | 0.4768 | -- | 0.946 | 4.52 | 56.05 | -- | 61.10 | -- |
Data as of Mar 04 2026. Currency figures normalised to Orchestra Biomed Holdings Inc's reporting currency: US Dollar USD
33.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| RTW Investments LPas of 23 Feb 2026 | 8.31m | 15.39% |
| Perceptive Advisors LLCas of 31 Dec 2025 | 5.13m | 9.50% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.37m | 2.54% |
| Alyeska Investment Group LPas of 31 Dec 2025 | 1.00m | 1.85% |
| Affinity Asset Advisors LLCas of 31 Dec 2025 | 572.80k | 1.06% |
| Geode Capital Management LLCas of 31 Dec 2025 | 473.36k | 0.88% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Dec 2025 | 364.65k | 0.68% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 347.80k | 0.65% |
| Charles Schwab Investment Management, Inc.as of 31 Dec 2025 | 263.79k | 0.49% |
| David M. Knott Partnershipas of 31 Dec 2025 | 250.00k | 0.46% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
